Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Mcleod

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Paediatrics & Child Health|September 24, 2020
Comprehensive care of the ambulatory child with cerebral palsy (GMFCS I and II): A Canadian perspectiveAnne Kawamura, Amber Makino, Scott McLeod
Vision Research|October 11, 2005
Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroidGerard A Lutty, D Scott McLeod
Paediatrics & Child Health|June 3, 2024
Les soins aux enfants et aux adolescents ayant la paralysie cérébrale (aux niveaux III à V du GMFCS)Scott McLeod, Amber Makino, Anne Kawamura
Progress in Retinal and Eye Research|October 31, 2017
Development of the hyaloid, choroidal and retinal vasculatures in the fetal human eyeGerard A Lutty, D Scott McLeod
Eye and Brain|May 26, 2017
Targeting VEGF in canine oxygen-induced retinopathy - a model for human retinopathy of prematurityD Scott McLeod, Gerard A Lutty
Progress in Retinal and Eye Research|February 25, 2003
Retinal vascular development and oxygen-induced retinopathy: a role for adenosineGerard A Lutty, D Scott McLeod
Paediatrics & Child Health|June 3, 2024
Care for children and youth with cerebral palsy (GMFCS levels III to V)Scott McLeod, Amber Makino, Anne Kawamura
Paediatrics & Child Health|September 24, 2020
Les soins complets de l'enfant ayant la paralysie cérébrale et capable de marcher (GMFCS I et II) : une perspective canadienneAnne Kawamura, Amber Makino, Scott McLeod
Paediatrics & Child Health|October 11, 2021
Parental evaluation of a revised autism spectrum disorder diagnostic process for children under 36 months of ageJean-François Lemay, Shauna Langenberger, Scott McLeod
Molecular Vision|May 13, 2005
Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eyeJohn Ash, D Scott McLeod, Gerard A Lutty
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Paediatrics & Child Health|September 24, 2020
Comprehensive care of the ambulatory child with cerebral palsy (GMFCS I and II): A Canadian perspectiveAnne Kawamura, Amber Makino, Scott McLeod
Vision Research|October 11, 2005
Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroidGerard A Lutty, D Scott McLeod
Paediatrics & Child Health|June 3, 2024
Les soins aux enfants et aux adolescents ayant la paralysie cérébrale (aux niveaux III à V du GMFCS)Scott McLeod, Amber Makino, Anne Kawamura
Progress in Retinal and Eye Research|October 31, 2017
Development of the hyaloid, choroidal and retinal vasculatures in the fetal human eyeGerard A Lutty, D Scott McLeod
Eye and Brain|May 26, 2017
Targeting VEGF in canine oxygen-induced retinopathy - a model for human retinopathy of prematurityD Scott McLeod, Gerard A Lutty
Progress in Retinal and Eye Research|February 25, 2003
Retinal vascular development and oxygen-induced retinopathy: a role for adenosineGerard A Lutty, D Scott McLeod
Paediatrics & Child Health|June 3, 2024
Care for children and youth with cerebral palsy (GMFCS levels III to V)Scott McLeod, Amber Makino, Anne Kawamura
Paediatrics & Child Health|September 24, 2020
Les soins complets de l'enfant ayant la paralysie cérébrale et capable de marcher (GMFCS I et II) : une perspective canadienneAnne Kawamura, Amber Makino, Scott McLeod
Paediatrics & Child Health|October 11, 2021
Parental evaluation of a revised autism spectrum disorder diagnostic process for children under 36 months of ageJean-François Lemay, Shauna Langenberger, Scott McLeod
Molecular Vision|May 13, 2005
Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eyeJohn Ash, D Scott McLeod, Gerard A Lutty
Pageof 9